公司资料
NGM Biopharmaceuticals 股价、新闻与催化剂
- 股票代码:
- NGM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 NGM 的收盘价变动背景。
公司概览
业务概览
NGM Biopharmaceuticals is a biotech company focused on metabolic, liver, and oncology programs. Its business has been shaped by a broad platform approach and ongoing portfolio decisions.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, NGM sits in specialty biotechnology.
商业模式特征
The company depends on pipeline prioritization, clinical data, and the ability to create value from a broad discovery engine.
生物医药行业定位
NGM is a platform biotech name whose valuation depends on the quality of its selected programs.
未来催化剂
- NGM is now largely a legacy and strategic-closeout story, so the catalysts are any asset monetization, wind-down, or portfolio-simplification update. The market is mainly waiting for clarity on the remaining corporate value.
近期新闻
新闻标题由机器翻译,详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。
